WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security ...

Biotechnology contributes to this aspect of the plastics industry while providing end-of-life waste management solutions via enzymatic recycling, facilitating monomer recovery under milder conditions ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting. And readers have made it easy for us—it’s clear what kind of story ...

to the Bronx, in New York. An oxygen sensor protein protects the enzymatic machinery of biological nitrogen fixation from serious damage, and its use in biotechnology could help to reduce the use ...

While only around 330 Boston-area biotech employees were impacted by layoffs in the first quarter of 2024, that number rose to over 1,810 workers in the second quarter and more than 1,400 people ...

HERE’S WHAT YOU NEED TO KNOW FLOWFLEX COVID TESTS ARE SOLD ALL OVER THE U.S. NATIONAL PHARMACY CHAINS. BUY THEM DIRECTLY FROM THE MANUFACTURER ACON LABS, BUT SMALLER, INDEPENDENT PHARMACIES ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs with high cash burn and no revenue. Biotech IPOs show resilience. Recent market ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance. New techniques are being made possible by advancements ...

Local biotech Heron Therapeutics is relocating its headquarters from San Diego to North Carolina, where it says the area’s burgeoning biotech scene “provides ample space for growth and ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...